165 related articles for article (PubMed ID: 31792390)
1. Acyl ethanolamides in Diabetes and Diabetic Nephropathy: Novel targets from untargeted plasma metabolomic profiles of South Asian Indian men.
Devi S; Nongkhlaw B; Limesh M; Pasanna RM; Thomas T; Kuriyan R; Kurpad AV; Mukhopadhyay A
Sci Rep; 2019 Dec; 9(1):18117. PubMed ID: 31792390
[TBL] [Abstract][Full Text] [Related]
2. Interpretable machine learning identifies metabolites associated with glomerular filtration rate in type 2 diabetes patients.
An TF; Zhang ZP; Xue JT; Luo WM; Li Y; Fang ZZ; Zong GW
Front Endocrinol (Lausanne); 2024; 15():1279034. PubMed ID: 38915893
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic study of the protective effect of Gandi capsule for diabetic nephropathy.
Liu Y; Chen X; Liu Y; Chen T; Zhang Q; Zhang H; Zhu Z; Chai Y; Zhang J
Chem Biol Interact; 2019 Dec; 314():108815. PubMed ID: 31499054
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics of non-diabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases.
Liu S; Guo Q; Han H; Cui P; Liu X; Miao L; Zou H; Sun G
Int Urol Nephrol; 2016 Oct; 48(10):1691-8. PubMed ID: 27272256
[TBL] [Abstract][Full Text] [Related]
5. Increased lipoxygenase and decreased cytochrome P450s metabolites correlated with the incidence of diabetic nephropathy: Potential role of eicosanoids from metabolomics in type 2 diabetic patients.
Peng L; Sun B; Liu Y; Huang J; Chen G; Zhang X; Chen C; Wang D; Wang G
Clin Exp Pharmacol Physiol; 2021 May; 48(5):679-685. PubMed ID: 33605471
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation.
Rovira-Llopis S; Escribano-Lopez I; Diaz-Morales N; Iannantuoni F; Lopez-Domenech S; Andújar I; Jover A; Pantoja J; Pallardo LM; Bañuls C; Victor VM
Cell Physiol Biochem; 2018; 50(3):1005-1014. PubMed ID: 30355913
[TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxyhexanoic Acid Predicts Early Renal Functional Decline in Type 2 Diabetes Patients with Microalbuminuria.
Tang X; You J; Liu D; Xia M; He L; Liu H
Kidney Blood Press Res; 2019; 44(2):245-263. PubMed ID: 31071709
[TBL] [Abstract][Full Text] [Related]
8. Role of aromatic amino acids in pathogeneses of diabetic nephropathy in Chinese patients with type 2 diabetes.
Zhang S; Li X; Luo H; Fang ZZ; Ai H
J Diabetes Complications; 2020 Oct; 34(10):107667. PubMed ID: 32674925
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in oxidative stress pathway genes and risk of diabetic nephropathy in South Indian type 2 diabetic patients.
Narne P; Ponnaluri KC; Siraj M; Ishaq M
Nephrology (Carlton); 2014 Oct; 19(10):623-9. PubMed ID: 25041504
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for Detecting Kidney Dysfunction in Type-2 Diabetics and Diabetic Nephropathy Subjects: A Case-Control Study to Identify Potential Biomarkers of DN to Stratify Risk of Progression in T2D Patients.
Harkin C; Cobice D; Brockbank S; Bolton S; Johnston F; Strzelecka A; Watt J; Kurth MJ; Lamont JV; Fitzgerald P; Moore T; Ruddock MW
Front Endocrinol (Lausanne); 2022; 13():887237. PubMed ID: 35846341
[TBL] [Abstract][Full Text] [Related]
11. Expression of Endothelial Cell Injury Marker Cd146 Correlates with Disease Severity and Predicts the Renal Outcomes in Patients with Diabetic Nephropathy.
Fan Y; Fei Y; Zheng L; Wang J; Xiao W; Wen J; Xu Y; Wang Y; He L; Guan J; Wei J; He JC; Wang N
Cell Physiol Biochem; 2018; 48(1):63-74. PubMed ID: 30001528
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic Nephropathy.
Gordin D; Shah H; Shinjo T; St-Louis R; Qi W; Park K; Paniagua SM; Pober DM; Wu IH; Bahnam V; Brissett MJ; Tinsley LJ; Dreyfuss JM; Pan H; Dong Y; Niewczas MA; Amenta P; Sadowski T; Kannt A; Keenan HA; King GL
Diabetes Care; 2019 Jul; 42(7):1263-1273. PubMed ID: 31076418
[TBL] [Abstract][Full Text] [Related]
13. YKL-40: A biomarker for early nephropathy in type 2 diabetic patients and its association with inflammatory cytokines.
Umapathy D; Dornadula S; Krishnamoorthy E; Mariappanadar V; Viswanathan V; Ramkumar KM
Immunobiology; 2018 Nov; 223(11):718-727. PubMed ID: 30077474
[TBL] [Abstract][Full Text] [Related]
14. Amino acid and lipid metabolism in post-gestational diabetes and progression to type 2 diabetes: A metabolic profiling study.
Lai M; Liu Y; Ronnett GV; Wu A; Cox BJ; Dai FF; Röst HL; Gunderson EP; Wheeler MB
PLoS Med; 2020 May; 17(5):e1003112. PubMed ID: 32433647
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of hsa-miR-152-3p are associated with diabetic nephropathy in patients with type 2 diabetes.
Roux M; Perret C; Feigerlova E; Mohand Oumoussa B; Saulnier PJ; Proust C; Trégouët DA; Hadjadj S
Nephrol Dial Transplant; 2018 Dec; 33(12):2201-2207. PubMed ID: 29361146
[TBL] [Abstract][Full Text] [Related]
16. Plasma Metabolomics Identifies Markers of Impaired Renal Function: A Meta-analysis of 3089 Persons with Type 2 Diabetes.
Tofte N; Vogelzangs N; Mook-Kanamori D; Brahimaj A; Nano J; Ahmadizar F; van Dijk KW; Frimodt-Møller M; Arts I; Beulens JWJ; Rutters F; van der Heijden AA; Kavousi M; Stehouwer CDA; Nijpels G; van Greevenbroek MMJ; van der Kallen CJH; Rossing P; Ahluwalia TS; 't Hart LM
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271379
[TBL] [Abstract][Full Text] [Related]
17. Untargeted metabolomic profiling reveals molecular signatures associated with type 2 diabetes in Nigerians.
Doumatey AP; Shriner D; Zhou J; Lei L; Chen G; Oluwasola-Taiwo O; Nkem S; Ogundeji A; Adebamowo SN; Bentley AR; Gouveia MH; Meeks KAC; Adebamowo CA; Adeyemo AA; Rotimi CN
Genome Med; 2024 Mar; 16(1):38. PubMed ID: 38444015
[TBL] [Abstract][Full Text] [Related]
18. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker.
Al-Kafaji G; Al-Mahroos G; Al-Muhtaresh HA; Skrypnyk C; Sabry MA; Ramadan AR
Exp Ther Med; 2016 Aug; 12(2):815-822. PubMed ID: 27446281
[TBL] [Abstract][Full Text] [Related]
20. Clinical predictors differentiating non-diabetic renal diseases from diabetic nephropathy in a large population of type 2 diabetes patients.
Dong Z; Wang Y; Qiu Q; Zhang X; Zhang L; Wu J; Wei R; Zhu H; Cai G; Sun X; Chen X
Diabetes Res Clin Pract; 2016 Nov; 121():112-118. PubMed ID: 27693840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
